mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels) Mar Riveiro-Barciela; Luisa Roade; Joan Martínez-Camprecios; Judit Vidal-González; Basilio Rodríguez-Diez; Manel Perelló; Guillermo Ortí; Virginia Robles-Alonso; Cristina Berastegui; Jordi Navarro; Fernando Martínez-Valle; Itxarone Bilbao; Lluis Castells; Meritxell Ventura-Cots; Jordi Llaneras; Ariadna Rando-Segura; Xavier Forns; Sabela Lens; Martín Prieto; María García-Eliz; Arkaitz Imaz; Francisco Rodríguez-Frías; Maria Buti; Rafael Esteban;

Documento de consenso de la Sociedad Española de Endoscopia Digestiva sobre SpyGlass-DS Ramón Sánchez-Ocaña; José Ramón Foruny Olcina; Juan Vila Costas; Francisco Gallego Rojo; Javier Jiménez Pérez; Enrique Domínguez-Muñoz; Ferrán González Huix; Vicente Pons Beltrán; Joan Gornals Soler; Eloy Sánchez Hernández; Cristina Gómez Oliva; Carlos Dolz Abadía; José Ramón Aparicio Tormo;

The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy Lydia Sastre; Mireia García-López; Sofía Pérez-del-Pulgar; Sabela Lens; Josep Costa; Miquel Navasa; Xavier Forns;